Nano Miscellaneous
Market Cap
₹132 Cr.
P/E
93.51

Key Ratios

Market cap
Market cap
132 Cr
PE
PE
93.51
Prom Holding
Prom Holding
65.99 %
ROE (%)
ROE (%)
11.94
ROCE (%)
ROCE (%)
12.78
Div Yield (%)
Div Yield (%)
-
Sales
Sales
270 Cr
OPM (%)
OPM (%)
3.16 %
Debt to Equity
Debt to Equity
0.22
Institutions
Institutions
2.56 %
Individual < 2 lac
Individual < 2 lac
19.24 %
No. of Shareholders
No. of Shareholders
15,176

About

Balaxi Ventures Limited, a professionally managed Listed Company, operates in the Pharmaceutic… Read more
Low
15
52W Range
High
53
  • Balaxi Pharma.
  • Alpa Laboratories
  • Krebs Biochem.&Inds

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

Edit rows

Forensics

3 Yes

Positive for this company

2 Neutral

Neutral for this company

11 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Product Wise Break-Up

Location Wise Break-Up

Therapeutic Area Break-Up

Drug Delivery Break-Up

Peer Comparison

Corporate Actions

Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less

FAQs on Balaxi Pharmaceuticals Ltd. Business

Balaxi Ventures Limited is a listed company managing procurement, production, supply chain, distribution, and point of sale for pharmaceutical, food products, and builders hardware through international wholesale trading.

Balaxi Pharma. major competitors are Krebs Biochem.&Inds, Alpa Laboratories, Kimia Biosciences, Panchsheel Organics, Denis Chem Lab, Makers Laboratories, Bharat Immunological.
Market Cap of Balaxi Pharma. is ₹131 Crs.
While the median market cap of its peers are ₹128 Crs.

Balaxi Pharma. seems to be less financially stable compared to its competitors.
Altman Z score of Balaxi Pharma. is 3.38 and is ranked 4 out of its 8 competitors.

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Mar Jun
Investor Presentation Mar Nov Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Sep
Conference Call Jun Sep
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material